Samuel Vasikaran
Samuel Vasikaran
Royal Perth Hospital
Verified email at health.wa.gov.au
Title
Cited by
Cited by
Year
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards
S Vasikaran, R Eastell, O Bruyère, AJ Foldes, P Garnero, A Griesmacher, ...
Osteoporosis international 22 (2), 391-420, 2011
8322011
The assessment of vertebral deformity: a method for use in population studies and clinical trials
EV McCloskey, TD Spector, KS Eyres, ED Fern, N O'rourke, S Vasikaran, ...
Osteoporosis International 3 (3), 138-147, 1993
5511993
Elimination and biochemical responses to intravenous alendronate in postmenopausal osteoporosis
SA Khan, JA Kanis, S Vasikaran, WF Kline, BK Matuszewski, ...
Journal of Bone and Mineral Research 12 (10), 1700-1707, 1997
2801997
International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis
S Vasikaran, C Cooper, R Eastell, A Griesmacher, HA Morris, T Trenti, ...
Clinical Chemistry and Laboratory Medicine (CCLM) 49 (8), 1271-1274, 2011
2592011
B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo …
Hankey GJ, Eikelboom JW, Baker RI, Gelavis A, Hickling SC, Jamrozik K, van ...
Lancet Neurol 9, 855-865, 2010
244*2010
Methylenetetrahydrofolate reductase gene and coronary artery disease
FM van Bockxmeer, CDS Mamotte, SD Vasikaran, RR Taylor
Circulation 95 (1), 21-23, 1997
2301997
Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir
D Nolan, R Upton, E McKinnon, M John, I James, B Adler, G Roff, ...
Aids 15 (10), 1275-1280, 2001
1882001
Current recommendations for laboratory testing and use of bone turnover markers in management of osteoporosis
J Lee, S Vasikaran
Annals of laboratory medicine 32 (2), 105-112, 2012
1722012
Current assays overestimate 25-hydroxyvitamin D3 and underestimate 25-hydroxyvitamin D2 compared with HPLC: need for assay-specific decision limits and metabolite-specific assays
P Glendenning, M Taranto, JM Noble, AA Musk, C Hammond, ...
Annals of clinical biochemistry 43 (1), 23-30, 2006
1362006
Bisphosphonates: an overview with special reference to alendronate
SD Vasikaran
Annals of clinical biochemistry 38 (6), 608-623, 2001
1352001
A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: effect on mood, cognition and quality of life
OP Almeida, NT Lautenschlager, S Vasikaran, P Leedman, A Gelavis, ...
Neurobiology of aging 27 (1), 141-149, 2006
1232006
A meta-analysis of reference markers of bone turnover for prediction of fracture
H Johansson, A Odén, JA Kanis, EV McCloskey, HA Morris, C Cooper, ...
Calcified tissue international 94 (5), 560-567, 2014
1162014
Effective treatment of malignant hypercalcaemia with a single intravenous infusion of clodronate
NP O'Rourke, EV McCloskey, S Vasikaran, K Eyres, D Fern, JA Kanis
British journal of cancer 67 (3), 560-563, 1993
1051993
A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone
JP Walsh, LC Ward, GO Stewart, RK Will, RA Criddle, RL Prince, ...
Bone 34 (4), 747-754, 2004
1042004
Association of cardiovascular risk factors and disease with depression in later life
OP Almeida, L Flicker, P Norman, GJ Hankey, S Vasikaran, ...
The American Journal of Geriatric Psychiatry 15 (6), 506-513, 2007
1032007
Subjective memory complaints with and without objective memory impairment: relationship with risk factors for dementia
NT Lautenschlager, L Flicker, S Vasikaran, P Leedman, OP Almeida
The American Journal of Geriatric Psychiatry 13 (8), 731-734, 2005
1032005
Utility of biochemical markers of bone turnover and bone mineral density in management of osteoporosis
SD Vasikaran
Critical reviews in clinical laboratory sciences 45 (2), 221-258, 2008
1012008
Contribution of the MTHFR gene to the causal pathway for depression, anxiety and cognitive impairment in later life
OP Almeida, L Flicker, NT Lautenschlager, P Leedman, S Vasikaran, ...
Neurobiology of aging 26 (2), 251-257, 2005
992005
Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol
P Glendenning, GT Chew, HM Seymour, MJ Gillett, PR Goldswain, ...
Bone 45 (5), 870-875, 2009
932009
Quality assessment of interpretative commenting in clinical chemistry
EM Lim, KA Sikaris, J Gill, J Calleja, PE Hickman, J Beilby, SD Vasikaran
Clinical chemistry 50 (3), 632-637, 2004
912004
The system can't perform the operation now. Try again later.
Articles 1–20